Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy

Michael Jeserich1, Daniela Föll, Manfred Olschewski

  • 1Department of Cardiology and Angiology, Albert Ludwig University of Freiburg, Freiburg, Germany. info@praxis-jeserich.de

Clinical Cardiology
|March 31, 2012
PubMed

Insights

Myocardial edema, a sign of inflammation, is present in patients with nonischemic dilated cardiomyopathy (DCM). This finding, detected via cardiovascular magnetic resonance, suggests a link between inflammation and DCM progression.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomarkers

Background:

  • Nonischemic dilated cardiomyopathy (DCM) presents significant mortality and morbidity risks.
  • Cardiovascular magnetic resonance (CMR) noninvasively assesses cardiac function, morphology, and myocardial edema.
  • Inflammatory pathways are implicated in the etiology and progression of chronic DCM.

Purpose of the Study:

  • To determine the incidence of myocardial edema in patients with nonischemic DCM.
  • To evaluate myocardial edema as a potential marker of myocardial inflammation in DCM.

Main Methods:

  • 31 patients with idiopathic DCM and 39 matched controls underwent CMR.
  • Electrocardiogram-triggered, T2-weighted imaging was used to assess myocardial edema.
  • Left ventricular function and volumes were analyzed; patient and control variables were compared using t tests and chi-squared tests.

Main Results:

  • Patients with DCM exhibited significantly higher global myocardial edema (increased signal intensity ratio) compared to controls (P = 0.0006).
  • Ejection fraction was markedly reduced in DCM patients (40.3%) versus controls (62.6%) (P < 0.0001).
  • A moderate negative correlation was observed between myocardial edema and ejection fraction (r = -0.39, P < 0.001).

Conclusions:

  • Myocardial edema is demonstrably associated with idiopathic nonischemic DCM.
  • These findings highlight the role of inflammation in DCM.
  • Further research is warranted to clarify the clinical and prognostic significance of myocardial edema in DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...